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Alopecia areata, an autoimmune disease affecting
anagen stage hair follicles, can be induced by graft-
ing spontaneous alopecia areata affected skin to nor-
mal-haired C3H/HeJ mice. As the onset of alopecia
areata can be signi®cantly retarded by anti-CD44
variant isoform 10 treatment, it was interesting to
explore the underlying disease mechanism. Two
weeks after transplanting alopecia areata affected
skin, expression of CD44 variant isoforms 3, 6, 7,
and 10 was strikingly upregulated as compared with
sham-grafted mice. By 6 wk after grafting, CD44
variant isoform levels had returned to normal,
whereas in draining lymph nodes, CD44 variant iso-
form expression was slightly decreased. Leukocytes
in the skin of mice with chronic alopecia areata
expressed a hematopoietic isoform of CD44 and
CD44 variant isoform 6 at an elevated level, but
CD44 variant isoform 3 expression was reduced.
Cytokine expression in leukocytes of chronic alope-
cia areata affected skin was higher than in normal-
haired controls. Cytokine expression also increased
postsurgery in sham and alopecia areata grafted
mice, but remained elevated only in mice receiving
alopecia areata affected skin. Finally, from the skin
of mice with chronic alopecia areata and of mice
transplanted with alopecia areata affected skin, an
increased number of CD4+ and CD8+ cells, but a
strongly decreased number of CD4+/CD25+ regula-
tory T cells was recovered. Thus, expression of
CD44 variant isoforms is important for the migration
of leukocytes during the initial period of alopecia
areata. CD44, however, is apparently not involved in
the maintenance of the disease state, which is charac-
terized by high cytokine expression levels, an
increased number of CD4+ and CD8+ cells, but a
low level of CD4+/CD25+ suppressor cells. Key
words: adhesion molecules/autoimmune disease/mouse
model. J Invest Dermatol 118:983±992, 2002
A
lopecia areata (AA) is an autoimmune disease invol-
ving focal perifollicular and intrafollicular in¯amma-
tion of anagen stage hair follicles. C3H/HeJ mice have
been previously investigated as an appropriate animal
model for AA (Sundberg et al, 1994; McElwee et al,
1998a, 1999a, b). Though only 20% of aged mice develop AA
spontaneously (Sundberg et al, 1994; McElwee et al, 2001), AA can
be induced in normal-haired C3H/HeJ mice by the transfer of AA-
affected skin or by subcutaneous injection of lymph node or spleen
cells (McElwee et al, 1998b).
There is ample evidence that lymphocytes show altered expres-
sion of adhesion molecules in allergic and autoimmune reactions
(reviewed in McMurray, 1996). Intercellular adhesion molecule
(ICAM)-1 is the best explored adhesion molecule in autoimmune
diseases (Roep et al, 1994; Bullard et al, 1997); however, there are
also several reports describing alterations in the intensity of CD44
expression as well as changes in the pattern of CD44 isoforms in
autoimmune disease (Budd et al, 1991; Wang et al, 1992; Haegel et
al, 1993; Nishikawa et al, 1993; Osada et al, 1995; Verdrengh et al,
1995; Harris et al, 1997; Estess et al, 1998). In rheumatoid arthritis
and in encephalomyelitis, upregulation of CD44 variant isoform
(CD44v) 6 expression and in autoimmune glomerulonephritis as
well as in ulcerative colitis upregulation of CD44v6 and CD44v9
has been described (reviewed in GuÈnthert et al, 1998).
Trinitrobenzene sulfonic acid-induced colitis, a mouse model of
Crohn's disease, essentially requires CD44v7 expression and can be
prevented and cured by an antibody speci®c for CD44v7 (Wittig et
al, 1998a, 2000). CD44v3 is required for leukocyte extravasation
and has been shown to be strongly upregulated in autoimmune
alterations of the skin (Seiter et al, 1998a, 1999). Finally, anti-
CD44v10 has been demonstrated to interfere with granuloma
formation and delayed type hypersensitivity (DTH) reactions
(RoÈsel et al, 1997). In particular, the onset of skin graft induced
AA in C3H/HeJ mice could be retarded by treatment with anti-
CD44v10 (Freyschmidt-Paul et al, 2000).
The involvement of CD44 in autoimmune reactions is not
surprising. CD44 is upregulated during the activation process (Arch
et al, 1992; Galandrini et al, 1993; Naujokas et al, 1993; Guo et al,
1996). Both the CD44 standard isoform (CD44s) and CD44 variant
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isoforms are supposed to function as costimulatory molecules (Arch
et al, 1992; Ayroldi et al, 1995; Galluzzo et al, 1995; Levesque and
Haynes, 1996; Taher et al, 1996; Ilangumaran et al, 1998; Seiter et
al, 1998, 2000; Dianzani et al, 1999; FoÈger et al, 2000; Yashiro-
Ohtani et al, 2000). Signi®cantly, CD44 is essentially required for
leukocyte extravasation (DeGrendele et al, 1996, 1997; Nandi et al,
2000). In addition, CD44v3 and CD44v10, which potentially carry
chondroitin sulfate and heparan sulfate side chains (Kugelman et al,
1992; Jackson et al, 1995) can function as cell surface proteoglycans
that bind cytokines and chemokines such as basic ®broblast growth
factor, osteopontin, macrophage in¯ammatory protein-1b, and
heparin-binding growth factor (Bennett et al, 1995; Tanaka et al,
1993; Weber et al, 1996; Grimme et al, 1999; van der Voort et al,
1999; Lin et al, 2000). Upregulation of proteoglycans as collectors
for cytokines and chemokines is well known to support extravasa-
tion of leukocytes (Henke et al, 1996; Ihrcke and Platt, 1996).
Besides costimulatory molecules, the activity of regulatory T cells
is of major importance in the progression of autoimmune diseases.
Autoreactive T cells can be readily identi®ed in the pool of
peripheral lymphocytes, their activation being prevented by
regulatory T cells (Shevach et al, 1998). Recently, it has been
noted that a population of CD4+/CD25+ T cells is essential for
maintaining homeostasis (Annacker et al, 2001). CD4+/CD25+ T
cells can suppress the induction of autoimmune disease and can
inhibit effector functions of autoreactive T cells (Suri-Payer et al,
1998). Besides being potent suppressors of CD4+/CD25± T cells,
they also interfere with effector functions of CD8+ cells (Gao et al,
1999). Immunosuppression via CD4+/CD25+ cells depends on
signaling via CTLA-4 and membrane bound transforming growth
factor and constitutive expression of CTLA-4 is primarily restricted
to CD4+/CD25+ regulatory T cells (Read et al, 2000; Takahashi et
al, 2000; Liu et al, 2001). It also has been shown that a CD40
de®ciency, which frequently is associated with autoimmune
alterations, is accompanied by a marked reduction in CD4+/
CD25+ regulatory T cells (Kumanogoh et al, 2001). The import-
ance of CD4+/CD25+ regulatory T cells has been described for
several autoimmune diseases (reviewed in Salomon and Bluestone,
2001).
In the search for the underlying mechanism of AA we de®ned
leukocyte subpopulations and their state of activity in skin and
draining lymph nodes of mice with chronic AA and in mice
transplanted with AA-affected skin. Only during the onset of
disease did skin in®ltrating leukocytes (SkIL) express CD44v3,
CD44v6, CD44v7, and CD44v10 at high levels. The chronic state
of disease was characterized by high-level cytokine expression and a
marked reduction in regulatory T cells.
MATERIALS AND METHODS
Mice and surgical procedure All C3H/HeJ mice were supplied from
stocks at the Jackson Laboratory (Bar Harbor, ME) speci®c pathogen-free
production facility. Mice received conventional low soy oil diet
(altromin 1434, Altromin GmBH, Lage, Germany) and acidi®ed water
(pH 2.8±3.0) ad libitum. Forty female mice in age-matched groups were
grafted at a mean age of 18 wk with AA-affected skin or normal skin
using procedures as described previously (McElwee et al, 1998b).
Circular sections of full thickness skin were pinch cut and one each
grafted to normal-haired C3H/HeJ mice. Immediately after the surgical
procedure all mice were housed in separate cages in isolation in a single
room at the University of Marburg for the duration of the study. Mice
were observed until necropsy and any changes in pelage coat quality
were recorded. All mice used in this study were con®rmed to have
accepted their skin graft.
Tissue and cell preparation Mice were killed at 2, 6, and 12 wk after
grafting and skin was excised from AA-affected and sham-grafted control
mice. Mice with chronic AA evident for 23 wk, along with
nonsurgically manipulated, normal-haired mice, were also necropsied.
Dorsal skin samples at the site of grafting and distant from the graft were
®xed in Fekete's acid/alcohol/formalin solution and paraf®n embedded.
Skin samples were also embedded in OCT compound (Tissue Tek,
Sakura, Zoeterwoude, the Netherlands) and snap frozen in liquid
nitrogen for subsequent immunohistology.
For ¯ow cytometry analyses, the entire dorsal and ventral skin,
draining lymph nodes, and spleen were collected. Single leukocyte cell
suspensions were prepared by pressing lymph nodes and spleens through
®ne gauze. Skin was carefully freed of fat and subcutaneous muscle tissue.
The skin was then put epidermis uppermost on sterile gauze in Petri
dishes and was covered with 25 ml of a solution of 1% trypsin, 50 U
collagenase per ml and 27 U DNase per ml. After 30 min the skin was
pressed towards the sterile gauze and isolated leukocytes were collected
in RPMI 1640 supplemented with 10% fetal bovine serum. The
procedure was repeated three times. The collected cells were washed,
resuspended in RPMI 1640 containing 10% fetal bovine serum plus
10±3 M HEPES buffer and were incubated for 2±3 h at 37°C, 5% CO2
in air in a humidi®ed atmosphere to allow for re-expression of digested
surface proteins. As in the ¯ow cytometry analysis keratinocytes could be
separated from leukocytes by size and granulation, preparations of SkIL
were directly used for ¯ow cytometry analysis after the recovery period.
Lymphocytes were enriched by Ficoll gradient centrifugation in selected
experiments. Fluorescence-activated cell sorter analysis of cells collected
from the interphase provided staining pro®les that did not differ from
those of unseparated, but gated populations of leukocytes. Lymph node
cells (LNC), spleen cells, and SkIL from two to three animals were
pooled. Viability was determined by Trypan blue exclusion and was in
the range of over 90% in LNC preparations and in the range of 70±80%
in SkIL preparations.
Antibodies The following monoclonal antibodies (MoAb) were used:
anti-mouse CD4 (clone RM4-5), biotinylated anti-mouse interleukin
(IL)-2 (clone JES6-5H4), IL-4 (clone BVD6-24G2), IL-6 (clone MP5-
32C11), IL-10 (clone JES3-16E3), IL-12 (clone C17.8), interferon
(IFN)-g (clone XMG1.2), and tumor necrosis factor (TNF)-a (clone
MP6-XT3); ¯uorescein isothiocyanate-conjugated anti-mouse CD25
(clone PC61), phycoerythrin (PE)-conjugated anti-CD28 (clone 37.51),
CD40 (clone 3/23), CD80 (clone 16-10A1), CD86 (clone GL1), and
surface IgM (clone R6-60.2) (all Pharmingen, Hamburg, Germany);
anti-CD8 (clone 53-6.7; Southern Biotechnology, Birmingham, AL);
anti-mouse CD4 (clone YTA 3.2.1), CD8 (clone YTS 169.4.2.1),
macrophage (clone YBM 6.6.10), ICAM-1 (clone YN1/1.7.4) (all
European Animal Cell Culture Collection, Porton Down, U.K.); LFA-1
(clone M17/5.2), dendritic cell (clone 33D1), and panCD44 (CD44s and
CD44v isoforms; clone IM7) (all American Type Culture Collection,
Manassus, VA); unconjugated or biotinylated anti-CD44v3 (clone
PTS33; Seiter et al 1999), CD44v6 (clone 11A6; Seiter et al, 2000),
CD44v7 (clone LN7.2; Wittig et al, 1998), CD44v10 (clone K926;
RoÈsel et al 1997), and VLA-4 (clone PS/2) kindly provided by K.
Miyake (Hession et al, 1992); secondary reagents were biotinylated, PE-
labeled and ¯uorescein isothiocyanate-labeled anti-rat IgG, anti-mouse
IgG, and streptavidin (all Dianova, Hamburg, Germany).
Histology and immunohistology Fixed tissue samples were sectioned
at 6 mm and stained with hematoxylin and eosin for histologic
evaluation. Immunohistology was performed on cryostat tissue sections as
described elsewhere (Freyschmidt-Paul et al, 2000). Brie¯y, tissue alkaline
phosphatase activity was ablated with levamisole solution and nonspeci®c
binding blocked using an avidin±biotin blocking kit (Vector
Laboratories, Burlingame, CA) and 2% normal goat serum. Cryostat
sections were exposed to the primary antibodies, biotinylated secondary
antibodies and alkaline phosphatase conjugated avidin±biotin complex
(Vector) solutions in sequence. Tissue sections were counter-stained with
Mayer's hematoxylin. The primary antibody was replaced with normal
rat IgG for negative controls. Digitized images were generated using a
Leica DMRBE Microscope equipped with a SPOT CCD camera from
Diagnostic Instruments and Software SPOT2.1.2 (Leica, Bensheim,
Germany).
Flow cytometry Each cell sample was aliquoted and incubated with
10 mg of the primary antibody per ml. Cells incubated with
unconjugated MoAb were subsequently incubated with the appropriate
anti-mouse or anti-rat PE-labeled secondary antibody. Cells labeled with
biotinylated MoAb were detected with streptavidin-PE. Negative
controls were incubated with a nonbinding primary antibody and the
same secondary reagents. For intracellular labeling of cytokines, cells
were ®xed and permeabilized in advance. For double ¯uorescence
analysis cells were ®rst labeled with a biotinylated antibody and
streptavidin-PE followed by exposure to the second, ¯uorescein
isothiocyanate-labeled antibody. Flow cytometry followed routine
procedures. A ¯uorescence-activated cell sorter ¯ow cytometer (Becton
Dickinson, Heidelberg, Germany) was used to analyze lymphocyte cell
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Figure 1. Enrichment of CD4+ and CD8+
cells in AA-affected skin. Skin containing
anagen stage hair follicles from mice with chronic
AA (A, G), normal-haired mice (B, H), mice
2 wk after receiving a transplant of AA-affected
skin (C, D, I, J), and sham-grafted mice 2 wk
after surgery (E, F, K, L) were labeled with anti-
CD4 (A±F) and anti-CD8 (G±L) MoAb. The
skin of normal-haired mice (B), sham-grafted mice
within the graft (E) and host skin immediately
adjacent to the graft site (F) contained isolated
CD4+ cells. Similarly, the skin of normal-haired
mice (H) and host skin immediately adjacent to
the graft site of sham-grafted mice (L) were
virtually devoid of CD8+ cells, whereas within the
graft of sham-grafted mice (K) isolated CD8+ cells
were apparent. In contrast, chronic AA-affected
hair follicles (A)and hair follicles within the AA-
affected skin transplant (C)exhibited an increased
number of perifollicular CD4+ cells. CD8+ cells
were observed in both perifollicular and
intrafollicular locations in chronic AA-affected
skin (G) and within the AA-affected skin graft (I).
In addition, host skin immediately adjacent to the
AA-affected skin graft site exhibited isolated
CD4+ (D) and CD8+ cells (J).Scale bar: 100 mm.
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populations. Cell viability was assessed by propidium iodide exclusion
and cell debris and dead cells were excluded from analysis. All
experiments were repeated at least three times. Values represent the
mean and, where indicated the SD. Signi®cance of differences was
calculated by the Student's t-test.
RESULTS AND DISCUSSION
Leukocyte subset distribution in the skin of AA-affected
mice As revealed by immunohistology and ¯ow cytometry, the
primary feature of chronic AA-affected skin was the increased
number of CD8+ and CD4+ cells associated with dystrophic anagen
stage hair follicles (Figs 1A, G and 2). An increased number of
CD4+ cells was also recovered 2 wk after surgery, irrespective of
whether AA-affected skin (Fig 1C, D) or normal-haired skin
(Fig 1E) was transplanted; however, only when AA-affected skin
had been transplanted was an elevated level of CD4+ cells still seen
6 wk after transplantation (Fig 2). There was also an increase in the
number of CD8+ cells in chronic AA-affected skin (Figs 1G and 2)
and to a lesser degree 2 and 6 wk after transplantation of AA-
affected skin (Figs 1I, J and 2). This was particularly apparent by
immunohistology with perifollicular and intrafollicular in®ltration
of anagen stage hair follicles of the graft and immediately adjacent
host skin. At 12 wk after grafting (data not shown), and in chronic
AA-affected mice, CD8+ cells were observed in and around anagen
stage hair follicles distant from the graft site. The apparently higher
percentage of monocytes in mice receiving a normal-haired graft
(Fig 2) is relative. It is brought about by the lower absolute number
of CD4+ cells. No particular changes were observed in draining
LNC from mice with chronic AA or receiving an AA affected
transplant (data not shown).
The costimulatory molecule CD28 and the ligands CD80 and
CD86 were unaltered in SkIL and draining LNC of mice with
chronic AA as compared with controls (Fig 3 and Table I). As
expected, early after surgery higher expression levels of CD80 and
CD86 were seen in SkIL and upregulation of CD28 expression was
seen in SkIL and draining LNC. The limited upregulation of CD80
and CD86 in the draining lymph nodes may be explained by the
low percentage of antigen-presenting cells present. Interestingly, in
the skin of mice with chronic AA, expression of CD40 was lower
than in controls. After transplanting AA-affected skin the percent-
age of CD40+ cells brie¯y increased, but remained below levels of
controls. Most striking was the consistently low-level expression of
CD25 in AA-affected skin transplanted mice. The phenomenon
was not seen in draining LNC.
CD4+/CD25+ cells primarily have immunosuppressive proper-
ties (Suri-Payer et al, 1998; Taams et al, 2001). Thus, it was of
interest whether these regulatory T cells were particularly low in
Figure 3. Expression of costimulatory
molecules and their ligands in SkIL of AA-
affected mice. SkIL of the mice described in
Fig 2 were labeled with anti-CD25, anti-CD28,
anti-CD40, anti-CD80, and anti-CD86 MoAb.
Live cells were gated and the percentage of
positive cells was evaluated. Mean 6 SD of three
experiments are shown. Signi®cant differences
(p < 0.01) as compared with non-AA-affected
mice are indicated by an asterisk.
Table I. Expression of costimulatory molecules and their
ligands in draining LNC of AA-affected mice
Donor
% Stained draining LNCa
CD25 CD28 CD40 CD80 CD86
Chronic AA 23.5 34.1* 24.7* 14.6 26.6
Control 20.3 44.3 14.7 10.7 20.9*
AA transplant, 2 wk 26.6 52.1* 22.6 22.2 27.2*
Control transplant, 2 wk 25.2 73.7 23.1 19.3 20.1
AA transplant, 6 wk 25.5 50.8* 21.9 19.2 21.3
Control transplant, 6 wk 18.9 60.7* 19.6 17.4 20.1
aMean values of three experiments are shown. Signi®cant differences (p
<0.01) as compared with non-AA-affected mice are indicated by an asterisk.
Figure 2. Leukocyte subset distribution in
the skin of AA-affected mice. SkIL were
prepared from mice (three per group) with
chronic AA and normal-haired mice as well as of
mice receiving a transplant of AA-affected skin or
of normal-haired skin at 2 and 6 wk after
transplantation. Isolated leukocytes were labeled
with anti-CD4, anti-CD8, anti-surface IgM, anti-
CD11b MoAb and an antibody speci®c for
dendritic cells. Live cells were gated and the
percentage of positive cells was evaluated.
Mean 6 SD of three experiments are shown.
Signi®cant differences (p < 0.01) as compared
with non-AA-affected mice are indicated by an
asterisk.
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spontaneous or skin graft induced AA. When SkIL of mice with
chronic AA and of mice transplanted with AA-affected skin were
double labeled with CD4-speci®c MoAb and CD25-speci®c
MoAb (Fig 4), hardly any cell coexpressed the two markers,
whereas a considerable proportion of the few CD4+ cells in the skin
of mice receiving a normal-haired transplant also expressed CD25.
Interestingly, in draining LNC and also in spleen cells of AA-
affected mice only a few CD4+/CD25+ cells were detected, even
though the overall number of CD25+ cells was unaltered.
CD4+/CD25+ T cells are known to be important for T cell
homeostasis (Annacker et al, 2001) and their transfer has been
repeatedly shown to abrogate autoimmune reactions (Suri-Payer et
al, 1999; Hara et al, 2001; Suri-Payer and Cantor, 2001). It is also
known that autoimmune reactions in the absence of CD40 are
characterized by a signi®cant decrease in the number of CD4+/
CD25+ regulatory T cells (Kumanogoh et al, 2001). Thus, the low
level of CD40+ and of CD4+/CD25+ cells in the skin of AA-
affected mice are in support of AA as an autoimmune disease on the
basis of an altered regulation of homeostasis (Annacker et al, 2001).
Expression of T helper 1 and 2 is increased in AA-affected
skin Because of the low level of CD4+/CD25+ cells in the skin
of AA-affected mice, it was of interest to know whether the low
level of potential suppressor cells may have a bearing on cytokine
expression (Fig 5). In SkIL of mice with chronic AA the
proin¯ammatory cytokines IL-6 and TNF, and also type 1 and
type 2 helper T cell cytokines (IL-4, IL-10, IL-12, IFN-g) were
expressed at a higher percentage than in controls. Two weeks after
Figure 5. Cytokine expression in SkIL of
AA-affected mice. SkIL of the mice described
in Fig 2 were ®xed and permeabilized and labeled
with anti-IL-2, anti-IL-4, anti-IL-10, anti-IL-12,
anti-IFN-g, and anti-TNF MoAb. The percentage
of positive cells was evaluated. Mean 6 SD of
three experiments are shown. Signi®cant
differences (p < 0.01) as compared with non-AA-
affected mice are indicated by an asterisk.
Figure 4. Decrease in CD4+/CD25+ lymphocytes in skin, lymph nodes, and spleen of AA-affected mice. SkIL, draining LNC, and spleen
cells from normal-haired mice, mice with chronic AA, sham-grafted mice, and mice receiving a transplant of AA-affected skin; the latter two mice at
2 wk after transplantation, were double labeled with PE-conjugated anti-CD4 and ¯uorescein isothiocyanate-conjugated anti-CD25 MoAb. The
population of lymphoblasts was gated. The negative control and the percentage of CD4-, CD25- and CD4/CD25 double positive cells in the gated
population are shown. Reduced numbers of CD4+/CD25+ cells were recovered from SkIL, draining LNC, and spleen cells of mice with chronic AA
and from mice transplanted with AA-affected skin.
Table II. Cytokine expression in draining LNC of AA-
affected mice
Donor
% Stained draining LNCa
IL-4 IL-6 IL-10 IL-12 IFN-g TNF
Chronic AA 28.7* 15.2 22.5* 39.6* 20.3 16.8
Control 14.7 12.0 13.1 26.9 19.3 14.1
AA transplant, 2 wk 44.9 21.8 26.4 46.9* 26.6 22.4
Control transplant, 2 wk 43.5 19.7 31.7 39.1 32.1 24.7
AA transplant, 6w 34.9 15.5 18.1* 33.7 18.5* 14.5
Control transplant, 6 wk 37.1 18.1 27.1 37.1 32.8 13.9
aMean values of three experiments are shown. Signi®cant differences
(p<0.01) as compared with non-AA-affected mice are indicated by an asterisk
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Figure 6. Expression of CD44 isoforms in SkIL and draining LNC of AA-affected mice. (A) Skin containing anagen stage hair follicles from
normal-haired mice, mice with chronic AA, mock transplanted mice, and mice receiving a transplant of AA-affected skin; the latter two mice at 2 wk
after transplantation, were labeled with biotinylated anti-panCD44, anti-CD44v3, anti-CD44v6, anti-CD44v7, and anti-CD44v10 MoAb, and were
counter-labeled with biotinylated goat anti-rat IgG or goat anti-mouse IgG and alkaline phosphatase conjugated avidin±biotin complex solutions in
sequence. Only the skin of mice receiving an AA-affected transplant contains a high number of CD44v3+ and of CD44v10+ leukocytes (scale
bar: 100 mm). The ®nding was con®rmed by ¯ow cytometry. (B) The population of lymphoblasts was gated in draining LNC and SkIL. The gated
populations, and the histogram of negative control of the gated population as well as the histograms of the gated population stained with anti-CD44v3,
anti-CD44v6, anti-CD44v7, and anti-CD44v10 in draining LNC and SkIL of normal-haired mice, sham-grafted, and AA-grafted mice at 2 wk after
surgery are shown. The cut-off level in the negative controls (M1) is also shown in the anti-CD44 stained probes. (C, D) Staining of the total
leukocyte population (excluding the keratinocytes in SkIL) with anti-panCD44, anti-CD44v3, anti-CD44v6, anti-CD44v7, and anti-CD44v10 MoAb
is presented. Mean 6 SD of three experiments are shown. Signi®cant differences (p < 0.01) as compared with non-AA-affected mice are indicated by
an asterisk.
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transplantation of either AA-affected or normal-haired skin,
expression of IL-2, IL-4, IL-6, and IL-12 was elevated as
compared with AA-affected and normal-haired mice. Expression
of TNF, IL-10, and IFN-g was upregulated in comparison with
normal-haired skin, but not above the level seen in chronic AA-
affected mice. At 12 wk after transplanting AA-affected or normal-
haired skin, the cytokine expression pattern resembled one of mice
with chronic AA and of normal-haired mice, respectively (data not
shown). In draining LNC of AA-affected mice only IL-4, IL-10,
and IL-12 were expressed at a higher level than in normal-haired
controls. Changes in the expression level after skin transplantation
resembled the ones seen in SkIL (Table II). Though the cytokine
pattern with high expression particularly of IL-12 and IL-4 does not
conclusively de®ne AA as T helper type 1 or 2 mediated, the
overall increase of cytokine expression in SkIL could well be due to
and supported by a decrease in regulatory T cells and, hence, to a
persistent activation of both T helper types 1 and 2 response
pathways.
Adhesion molecules in chronic AA and after transplantation
of AA-affected skin Autoimmune diseases of the skin are
frequently accompanied by altered expression of adhesion
molecules, a feature that may be of therapeutic relevance (Wang
et al, 1992; Aziz and Wake®eld, 1995; Nousari and Anhalt, 1995;
Grif®ths et al, 1996; ZoÈller, 2001). Previously, it has been shown
that DTH reactions can be mitigated by anti-CD44v3 and anti-
CD44v10 treatment (RoÈsel et al, 1997; Seiter et al, 1999) and, in
particular, the onset of AA could be retarded by treatment with
anti-CD44v10 (Freyschmidt-Paul et al, 2000).
Yet, in SkIL of mice with chronic AA expression of CD44v3
was slightly reduced and expression of CD44v7 and CD44v10 was
largely unaltered. Only expression of panCD44 and CD44v6 was
slightly elevated; however, 2 wk after transplanting AA-affected
skin, CD44v3, CD44v6, CD44v7, and CD44v10 were expressed at
high levels on SkIL. This accounted for the total populations of
leukocytes (Fig 6A, C) and, more pronounced, for the population
of lymphoblasts (Fig 6B). Except for CD44v7, expression levels of
CD44v isoforms had returned to control levels by 6 wk after skin
transplantation (Fig 6C).
In draining LNC of mice with chronic AA expression of
panCD44 and of all tested CD44v isoforms was unaltered or
reduced. Two weeks after surgery expression of CD44v6 was
strongly upregulated regardless of whether normal-haired or AA-
affected skin had been transplanted. Expression of CD44v7, too,
was upregulated 2 wk after surgery, upregulation being more
pronounced in draining LNC of sham than of AA transplanted
mice. As described for SkIL, changes in CD44 expression were seen
in the total population of LNC (Fig 6D) and, more pronounced,
in lymphoblasts (Fig 6B).
No particular changes were seen in expression of VLA-4
(CD49d) (data not shown). In SkIL and draining LNC of AA-
affected mice LFA-1 (CD11a) and ICAM-1 (CD54) expression was
slightly reduced as compared with controls. The phenomenon was
not seen within the ®rst weeks after transplantation of AA-affected
skin (Table III).
From these analyses it was concluded that expression of CD44
has a signi®cant bearing on the initiation of AA. We did not
observe major changes in the expression pro®le of ICAM-1 in AA,
although expression of ICAM-1 is well known to be of importance
in a variety of autoimmune diseases of the skin (Bullard et al, 1997;
Gilhar et al, 1998; Reich et al, 1999). We also only observed minor
changes in the expression of LFA-1; however, it is noteworthy that
the changes in expression of LFA-1 and ICAM-1 on SkIL re¯ected
those observed in CD44v3 expression, i.e., lower levels in chronic
AA than in controls and upregulation after transplantation of AA-
affected skin. Interestingly, upregulation and even de novo expres-
sion of LFA-1 will be induced by CD44v3 ligand binding (P.
Engel, unpublished ®nding).
Increased expression of CD44v6 in autoimmune disease and
DTH reactions has been repeatedly described (Laman et al, 1998;
Seiter et al, 1998b; Wittig et al, 1999). Though expression of
CD44v6 could not be demonstrated by immunohistology on SkIL
of patients with autoimmune diseases affecting the skin (Seiter et al,
1998a), this failure could have been due to masking of the epitope
as SkIL frequently express CD44v3 (Seiter et al, 1998a) known to
be decorated by a heparan sulfate side chain (Jackson et al, 1995).
CD44v6 is transiently expressed, predominantly on CD8+ cells,
during T cell activation (Seiter et al, 2000). Thus, the slight increase
in CD44v6 expression on SkIL of mice with chronic AA and the
higher expression level after skin transplantation are consistent with
an activated state of a minority of CD8+ cells in chronic AA and
during induction of AA. Expression of CD44v7 is also linked to
leukocyte activation. CD44v7 is expressed by antigen-presenting
cells and T helper cells (Wittig et al, 1998, 1999; Seiter et al, 2000).
Its expression is essential for the induction of a chronic in¯amma-
tory bowel disease by trinitrobenzene sulfonic acid treatment
(Wittig et al, 1998, 2000). The data suggest that CD44v7 interferes
with activation induced cell death, thus allowing for a perpetuation
of in¯ammation (Wittig et al, 2000). These features could explain
the strong increase after skin transplantation and the long-lasting
persistence after the transfer of AA-affected skin. The unaltered
level in preparations of SkIL of mice with chronic AA may be
explained by the relatively low number of activated leukocytes
during the chronic stage of the disease.
Of particular concern in autoimmune diseases of the skin are
CD44v3 and CD44v10. Low-level expression of CD44v3 has been
described on leukocytes in unaltered skin, but expression of this
particular CD44 variant isoform is strongly upregulated on SkIL of
patients with autoimmune disease (Seiter et al, 1998a). CD44v3 is
expressed on monocytes and CD4+ T cells. According to previous
®ndings, CD44v3 is essentially required for leukocyte extravasation
(Seiter et al, 1998a, 1999). CD44v10, although only upregulated in
a low percentage of patients with bullous pemphigoid, lupus
erythematosus, and morphea, and in 100% of patients with various
forms of vasculitis (Seiter et al, 1998a), is predominantly expressed
by monocytes and, as demonstrated in a DTH model system,
supports monocyte extravasation (RoÈsel et al, 1997). CD44v3 is
known to bind basic ®broblast growth factor (Bennett et al, 1995;
Grimme et al, 1999). CD44 molecules are also known as a ligand
for osteopontin (Weber et al, 1996; Katagiri et al, 1999). Evaluating
the binding of a CD44s and a CD44v10 receptor globulin to
osteopontin, only the latter was found to bind (P. Engel and M.
ZoÈller, in preparation). Both basic ®broblast growth factor and
osteopontin are known to be expressed by activated endothelial
cells (Faris et al, 1998; Fischer et al, 1997; Xie et al, 2001). Thus the
expression of the corresponding receptors CD44v3 and CD44v10
on leukocytes will greatly facilitate their adhesion and migration.
We do not know whether expression of CD44v3 and CD44v10 is
actively upregulated or whether CD44v3+ and CD44v10+
leukocytes are selectively recruited towards the skin. The ®nding
that expression of CD44v3 and CD44v10 was reduced in draining
LNC suggests the latter interpretation.
Table III. LFA-1 (CD11a) and ICAM-1 (CD54) expression
in SkIL and draining LNC of AA-affected mice
Donor
% Stained SkILa % Stained draining LNCa
CD11a CD54 CD11a CD54
Chronic AA 36.6* 58.3* 72.7* 68.2*
Control 44.4 72.7 85.9 86.2*
AA transplant, 2 wk 54.8 87.8 90.4 92.2
Control transplant, 2 wk 49.7 88.4* 89.9 94.1
AA transplant, 6 wk 41.9* 77.7 70.1* 72.2*
Control transplant, 6 wk 48.8 77.2* 82.2 82.7
aMean values of three experiments are shown. Signi®cant differences (p <0.01)
as compared with non-AA-affected mice are indicated by an asterisk.
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Taken together, the analysis of the skin of mice with chronic AA
and of mice receiving a transplant of AA-affected skin supports the
concept of AA as an autoimmune disease. Though our ®ndings did
not provide clear evidence for a uniquely T helper type 1-mediated
disease, the data suggest that autoaggression is due to a defect in
regulatory/suppressor CD4+/CD25+ cells that is associated with
low-level CD40 expression. Recruitment of leukocytes towards
the skin appears to rely mostly on CD44v3 and CD44v10. As these
molecules are expressed at low levels in chronic AA, their blockade
is unlikely to be of any therapeutic bene®t at this stage of the
disease. Owing to the requirement of CD44v3 and CD44v10 for
leukocyte extravasation (RoÈsel et al, 1997; Seiter et al, 1999),
however, the onset of disease or exacerbation of disease could be
prevented by their blockade, as has already been demonstrated for
CD44v10 (Freyschmidt-Paul et al, 2000).
The authors gratefully acknowledge the technical assistance of Mrs S. Hummel and
Mr M. Vitacolonna. This work was supported by the Deutsche
Forschungsgemeinschaft, MZ 40/7-2 (MZ) and Ho 1598/8-1 (RH), and in
part by an Ernst Schering Research Foundation fellowship (KJM).
REFERENCES
Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Barbosa TC, Cumano A,
Bandeira A: CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T
cells through the production of IL-10. J Immunol 166:3008±3018, 2001
Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, ZoÈller M:
Participation of a metastasis-inducing splice variant of CD44 in normal
immune response. Science 257:682±685, 1992
Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C: CD44 (Pgp-
1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672±2678,
1995
Aziz KE, Wake®eld D: In vivo and in vitro expression of adhesion molecules by
peripheral blood lymphocytes from patients with primary SjoÈgren's syndrome.
Culture-associated enhancement of LECAM-1 and CD44. Rheumatol Int
15:69±74, 1995
Bennett KL, Jackson DG, Simon JC, et al: CD44 isoforms containing exon v3 are
responsible for the presentation of heparin-binding growth factor. J Cell Biol
128:687±698, 1995
Budd RC, Schumacher JH, Winslow G, Mosmann TR: Elevated production of
interferon-gamma and interleukin 4 by mature T cells from autoimmune lpr
mice correlates with Pgp-1 (CD44) expression. Eur J Immunol 21:1081±1084,
1991
Bullard DC, King PD, Hicks MJ, Dupont B, Beaudet AL, Elkon KB: Intercellular
adhesion molecule-1 de®ciency protects MRL/MpJ-Fas (lpr) mice from early
lethality. J Immunol 15(159):2058±2067, 1997
DeGrendele HC, Estess P, Picker LJ, Siegelman MH: CD44 and its ligand
hyaluronate mediate rolling under physiologic ¯ow: a novel lymphocyte-
endothelial cell primary adhesion pathway. J Exp Med 183:1119±1130, 1996
DeGrendele HC, Estess P, Siegelman MH: Requirement for CD44 in activated T
cell extravasation into an in¯ammatory site. Science 278:672±675, 1997
Dianzani U, Bragardo M, Tosti A, et al: CD44 signaling through p56lck involves
lateral association with CD4 in human CD4+ T cells. Int Immunol 11:1085±
1092, 1999
Estess P, DeGrendele HC, Pascual V, Siegelman MH: Functional activation of
lymphocyte CD44 in peripheral blood is a marker of autoimmune disease
activity. J Clin Invest 102:1173±1182, 1998
Faris M, Ensoli B, Kokot N, Nel AE: In¯ammatory cytokines induce the expression
of basic ®broblast growth factor (bFGF) isoforms required for the growth of
Kaposi's sarcoma and endothelial cells through the activation of AP-1 response
elements in the bFGF promoter. AIDS 12:19±27, 1998
Fischer TA, Ungureanu-Longrois D, Singh K, et al: Regulation of bFGF expression
and ANG II secretion in cardiac myocytes and microvascular endothelial cells.
Am J Physiol 272:958±968, 1997
FoÈger N, Marhaba R, ZoÈller M: CD44 supports T cell proliferation and apoptosis by
apposition of protein kinases. Eur J Immunol 30:2888±2899, 2000
Freyschmidt-Paul P, Seiter S, ZoÈller M, et al: Treatment with an anti-CD44v10-
speci®c antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J Invest
Dermatol 115:653±657, 2000
Galandrini R, Albi N, Tripodi G, et al: Antibodies to CD44 trigger effector functions
of human T cell clones. J Immunol 150:4225±4231, 1993
Galluzzo E, Albi N, Fiorucci S, et al: Involvement of CD44 variant isoforms in
hyaluronate adhesion by human activated T cells. Eur J Immunol 25:2932±2939,
1995
Gao Q, Rouse TM, Kazmerzak K, Field EH: CD4+CD25+ cells regulate CD8 cell
anergy in neonatal tolerant mice. Transplant 68:1891±1897, 1999
Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS: Autoimmune hair loss
(alopecia areata) transferred by T lymphocytes to human scalp explants on
SCID mice. J Clin Invest 101:62±67, 1998
Grif®ths CE, Boffa MJ, Gallatin WM, Martin S: Elevated levels of circulating
intercellular adhesion molecule-3 (cICAM-3) in psoriasis. Acta Derm Venereol
76:2±5, 1996
Grimme HU, Termeer CC, Bennett KL, Weiss JM, Schopf E, Aruffo A, Simon JC:
Colocalization of basic ®broblast growth factor and CD44 isoforms containing
the variably spliced exon v3 (CD44v3) in normal skin and in epidermal skin
cancers. Br J Dermatol 141:824±832, 1999
GuÈnthert U, SchwaÈrzler C, Wittig B, et al: Functional involvement of CD44, a
family of cell adhesion molecules, in immune responses, tumour progression
and haematopoiesis. Adv Exp Med Biol 45:143±149, 1998
Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Lia Y: Identi®cation of a costimulatory
molecule rapidly induced by CD40L as CD44H. J Exp Med 184:955±961, 1996
Haegel H, ToÈlg C, Hofmann M, Ceredig R: Activated mouse astrocytes and T cells
express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell
Biol 122:1067±1077, 1993
Hara M, Kingsley CI, Niimi M et al: IL-10 is required for regulatory T cells to
mediate tolerance to alloantigens in vivo. J Immunol 166:3789±3796, 2001
Harris AJ, Dean D, Burge S, Wojnarowska F: Changes in CD44 isoform expression
during in¯ammatory skin disease. Clin Exp Dermatol 22:128±133, 1997
Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB: CD44-related
chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor
cell invasion, mediates endothelial cell migration on ®brinogen and invasion
into a ®brin matrix. J Clin Invest 97:2541±2552, 1996
Hession C, Moy P, Tizard R, et al: Cloning of murine and rat vascular cell adhesion
molecule-1. Biochem Biophys Res Commun 183:163±169, 1992
Ihrcke NS, Platt JL: Shedding of heparan sulfate proteoglycan by stimulated
endothelial cells: evidence for proteolysis of cell-surface molecules. J Cell
Physiol 168:625±637, 1996
Ilangumaran S, Briol A, Hoessli DC: CD44 selectively associates with active Src
family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma
membrane domains of human peripheral blood lymphocytes. Blood 91:3901±
3398, 1998
Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan
forms of the lymphocyte homing receptor CD44 are alternatively spliced
variants containing the v3 exon. J Cell Biol 128:673±685, 1995
Katagiri YU, Sleeman J, Fujii H, et al: CD44 variants but not CD44s cooperate with
beta1-containing integrins to permit cells to bind to osteopontin independently
of arginine-glycine-aspartic acid, thereby stimulating cell motility and
chemotaxis. Cancer Res 59:219±226, 1999
Kugelman LC, Ganguly S, Haggerty JG, Weissman SM, Milstone LM: The core
protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an
alternative form of CD44. J Invest Dermatol 99:381±385, 1992
Kumanogoh A, Wang X, Lee I, et al: Increased T cell autoreactivity in the absence of
CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell
development. J Immunol 166:353±360, 2001
Laman JD, Maassen CB, Schellekens MM, et al: Therapy with antibodies against
CD40L (CD154) and CD44-variant isoforms reduces experimental
autoimmune encephalomyelitis induced by a proteolipid protein peptide.
Mult Scler 4:147±153, 1998
Levesque MC, Haynes BF: In vitro culture of human peripheral blood monocytes
induces hyaluronan binding and up-regulates monocyte variant CD44 isoform
expression. J Immunol 156:1557±1565, 1996
Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, Yang-Yen HF: Coupling of
osteopontin and its cell surface receptor CD44 to the cell survival response
elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor.
Mol Cell Biol 20:2734±2742, 2000
Liu Z, Geboes K, Hellings P, et al: B7 interactions with CD28 and CTLA-4 control
tolerance or induction of mucosal in¯ammation in chronic experimental colitis.
J Immunol 167:1830±1838, 2001
McElwee KJ, Boggess D, Olivry T, et al: Comparison of alopecia areata in human and
nonhuman mammalian species. Pathobiology 66:90±107, 1998a
McElwee KJ, Boggess D, King LE Jr, Sundberg JP: Experimental induction of
alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J
Invest Dermatol 111:797±803, 1998b
McElwee KJ, Boggess D, Miller J, King LE Jr, Sundberg JP: Spontaneous alopecia
areata-like hair loss in one congenic and seven inbred laboratory mouse strains.
J Invest Dermatol Symp Proc 4:202±206, 1999a
McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP: Alopecia areata: an
autoimmune disease? Exp Dermatol 8:371±379, 1999b
McElwee KJ, Freyschmidt-Paul P, Ziegler A, Happle R, Hoffmann R: Genetic
susceptibility and severity of alopecia areata in human and animal models. Eur J
Dermatol 11:11±16, 2001
McMurray RW: Adhesion molecules in autoimmune disease. Semin Arthritis Rheum
25:215±233, 1996
Nandi A, Estess P, Siegelman MH: Hyaluronan anchoring and regulation on the
surface of vascular endothelial cells is mediated through the functionally active
form of CD44. J Biol Chem 275:14939±14948, 2000
Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J: The chondroitin
sulfate form of invariant chain can enhance stimulation of T cell responses
through interaction with CD44. Cell 74:257±268, 1993
Nishikawa K, Andres G, Bhan AK, McCluskey RT, Collins AB, Stow JL,
Stamenkovic I: Hyaluronate is a component of crescents in rat autoimmune
glomerulonephritis. Lab Invest 68:146±153, 1993
Nousari HC, Anhalt GJ: Bullous skin diseases. Curr Opin Immunol 7:844±852, 1995
Osada A, Nakashima H, Furue M, Tamaki K: Up-regulation of CD44 expression by
tumor necrosis factor-alpha is neutralized by interleukin-10 in Langerhans cells.
J Invest Dermatol 105:124±127, 1995
VOL. 118, NO. 6 JUNE 2002 ALOPECIA AREATA AND CD44 991
Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays
an essential role in the function of CD25(+) CD4(+) regulatory cells that
control intestinal in¯ammation. J Exp Med 192:295±302, 2000
Reich K, Brinck U, Letschert M, et al: Graft-versus-host disease-like
immunophenotype and apoptotic keratinocyte death in paraneoplastic
pemphigus. Br J Dermatol 141:739±746, 1999
Roep B, Heidenthal E, deVries RR, Kolb H, Martin S: Soluble forms of intercellular
adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 343:1590±
1593, 1994
RoÈsel M, Seiter S, ZoÈller M: CD44v10 expression in the mouse and functional
activity in delayed type hypersensitivity. J Cell Physiol 171:305±317, 1997
Salomon B, Bluestone JA: Complexities of CD28/B7: CTLA-4 costimulatory
pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225±252,
2001
Seiter S, Schadendorf D, Tilgen W, ZoÈller M: CD44 variant isoform expression in a
variety of skin-associated autoimmune diseases. Clin Immunol Immunopathol
89:79±93, 1998a
Seiter S, Weber B, Tilgen W, ZoÈller M: Down-modulation of host reactivity by anti-
CD44 in skin transplantation. Transplantation 66:778±791, 1998b
Seiter S, Engel P, FoÈhr N, ZoÈller M: Mitigation of delayed-type hypersensitivity
reactions by a CD44 variant isoform v3-speci®c antibody: blockade of
leukocyte egress. J Invest Dermatol 113:11±21, 1999
Seiter S, Schmidt DS, ZoÈller M: The CD44 variant isoforms CD44v6 and CD44v7
are expressed by distinct leukocyte subpopulations and exert non-overlapping
functional activities. Int Immunol 12:37±49, 2000
Shevach EM, Thornton A, Suri-Payer E: T lymphocyte-mediated control of
autoimmunity. Novartis Found Symp 215:200±211, 1998
Sundberg JP, Cordy WR, King LE Jr: Alopecia areata in aging C3H/HeJ mice. J
Invest Dermatol 102:847±856, 1994
Suri-Payer E, Amar AZ, Thornton AM, Shevach EM: CD4+CD25+ T cells inhibit
both the induction and effector function of autoreactive T cells and represent a
unique lineage of immunoregulatory cells. J Immunol 160:1212±1218, 1998
Suri-Payer E, Amar AZ, McHugh R, Natarajan K, Margulies DH, Shevach EM:
Post-thymectomy autoimmune gastritis. ®ne speci®city and pathogenicity of
anti-H/K ATPase-reactive T cells. Eur J Immunol 29:669±677, 1999
Suri-Payer E, Cantor H: Differential cytokine requirements for regulation of
autoimmune gastritis and colitis by CD4(+) CD25(+) T cells. J Autoimmun
16:115±123, 2001
Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human
anergic/suppressive CD4(+) CD25(+) T cells: a highly differentiated and
apoptosis-prone population. Eur J Immunol 31:1122±1131, 2001
Taher TE, Smit L, Grif®oen AW, Schilder-Tol EJ, Borst J, Pals ST: Signaling
through CD44 is mediated by tyrosine kinases. Association with p56lck in T
lymphocytes. J Biol Chem 271:2863±2867, 1996
Takahashi T, Tagami T, Yamazaki S, et al: Immunologic self-tolerance maintained by
CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T
lymphocyte-associated antigen 4. J Exp Med 192:303±310, 2000
Tanaka AS, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T cell
adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature
361:79±82, 1993
Verdrengh M, Holmdahl R, Tarkowski A: Administration of antibodies to
hyaluronanreceptor (CD44) delays the start and ameliorates the severity of
collagen II arthritis. Scand J Immunol 42:353±358, 1995
van der Voort R, Taher TE, Wielenga VJ, et al: Heparan sulfate-modi®ed CD44
promotes hepatocyte growth factor/scatter factor-induced signal transduction
through the receptor tyrosine kinase c-Met. J Biol Chem 274:6499±6506, 1999
Wang W, Kobayashi S, Uede T: Dysregulated expression of cellular adhesion
molecules in autoimmune-prone mice. J Dermatol 19:831±835, 1992
Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor±ligand interaction between
CD44 and osteopontin (Eta-1). Science 271:509±512, 1996
Wittig B, SchwaÈrzler C, FoÈhr N, GuÈnthert U, ZoÈller M: Curative treatment of an
experimentally induced colitis by a CD44 variant V7-speci®c antibody. J
Immunol 161:1069±1073, 1998
Wittig B, Seiter S, Schmidt DS, Zuber M, Neurath M, ZoÈller M: CD44 variant
isoforms on blood leukocytes in chronic in¯ammatory bowel disease and other
systemic autoimmune diseases. Lab Invest 79:747±759, 1999
Wittig BM, Johansson B, ZoÈller M, SchwaÈrzler C, GuÈnthert U: Abrogation of
experimental colitis correlates with increased apoptosis in mice de®cient for
CD44 variant exon 7 (CD44v7). J Exp Med 191:2053±2064, 2000
Xie Z, Pimental DR, Lohan S, Vasertriger A, Pligavko C, Colucci WS, Singh K:
Regulation of angiotensin II-stimulated osteopontin expression in cardiac
microvascular endothelial cells: role of p42/44 mitogen-activated protein
kinase and reactive oxygen species. J Cell Physiol 188:132±138, 2001
Yashiro-Ohtani Y, Zhou XY, Toyo-Oka K, et al: Non-CD28 costimulatory
molecules present in T cell rafts induce T cell costimulation by enhancing the
association of TCR with rafts. J Immunol 164:1251±1259, 2000
ZoÈller M: Costimulatory molecules and their ligands as therapeutic targets in
autoimmune disease. Eur J Dermatol 11:335±342, 2001
992 ZOÈ LLER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
